166 related articles for article (PubMed ID: 11291053)
1. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer.
Schulte KM; Beyer A; Köhrer K; Oberhäuser S; Röher HD
Int J Cancer; 2001 Apr; 92(2):249-56. PubMed ID: 11291053
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.
An S; Bleu T; Zheng Y; Goetzl EJ
Mol Pharmacol; 1998 Nov; 54(5):881-8. PubMed ID: 9804623
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.
An S; Bleu T; Hallmark OG; Goetzl EJ
J Biol Chem; 1998 Apr; 273(14):7906-10. PubMed ID: 9525886
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).
Contos JJ; Ishii I; Fukushima N; Kingsbury MA; Ye X; Kawamura S; Brown JH; Chun J
Mol Cell Biol; 2002 Oct; 22(19):6921-9. PubMed ID: 12215548
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.
Hama K; Bandoh K; Kakehi Y; Aoki J; Arai H
FEBS Lett; 2002 Jul; 523(1-3):187-92. PubMed ID: 12123830
[TBL] [Abstract][Full Text] [Related]
8. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
Mills GB; Eder A; Fang X; Hasegawa Y; Mao M; Lu Y; Tanyi J; Tabassam FH; Wiener J; Lapushin R; Yu S; Parrott JA; Compton T; Tribley W; Fishman D; Stack MS; Gaudette D; Jaffe R; Furui T; Aoki J; Erickson JR
Cancer Treat Res; 2002; 107():259-83. PubMed ID: 11775454
[TBL] [Abstract][Full Text] [Related]
9. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
Fang X; Gaudette D; Furui T; Mao M; Estrella V; Eder A; Pustilnik T; Sasagawa T; Lapushin R; Yu S; Jaffe RB; Wiener JR; Erickson JR; Mills GB
Ann N Y Acad Sci; 2000 Apr; 905():188-208. PubMed ID: 10818454
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid.
An S; Dickens MA; Bleu T; Hallmark OG; Goetzl EJ
Biochem Biophys Res Commun; 1997 Feb; 231(3):619-22. PubMed ID: 9070858
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
Hernández M; Barrero MJ; Crespo MS; Nieto ML
J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
[TBL] [Abstract][Full Text] [Related]
14. EDG receptors and hepatic pathophysiology of LPA and S1P: EDG-ology of liver injury.
Svetlov SI; Sautin YY; Crawford JM
Biochim Biophys Acta; 2002 May; 1582(1-3):251-6. PubMed ID: 12069835
[TBL] [Abstract][Full Text] [Related]
15. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K
FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid receptors.
Contos JJ; Ishii I; Chun J
Mol Pharmacol; 2000 Dec; 58(6):1188-96. PubMed ID: 11093753
[TBL] [Abstract][Full Text] [Related]
18. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
Takuwa Y; Takuwa N; Sugimoto N
J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
[TBL] [Abstract][Full Text] [Related]
20. Native and recombinant human Edg4 receptor-mediated Ca(2+) signalling.
Simpson PB; Villullas IR; Schurov I; Kerby J; Millard R; Haldon C; Beer MS; McAllister G
Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):31-40. PubMed ID: 15090154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
